Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  milatuzumab-doxorubicin antibody-drug conjugate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: IM-T-hLL1-DOX-02, NCI-2013-00484, NCT01585688
Start Over